教室関連

教室業績 2014年

英文原著 英文総説 英文著書
2017年 2016年 2015年 2014年
2013年 2012年 2011年 2010年
2009年 2008年 2007年 2006年
2005年以前

英文原著

2014年
Nishide T, Hayakawa N, Kimura I, Nakanishi M, Yagi Y, Shibuya E, Mizuki N: Postoperative refractive error following cataract surgery after the first attack of acute primary angle closure. Int Ophthalmol. 34(4): 805-808, 2014.
Kaburaki T, Namba K, Sonoda K, Kezuka T, Keino H, Ito T, Kamoi K, Nakai K, Mizuki N, Ohguro N and the Ocular Behçet Disease Research Group of Japan. Behçet’s disease ocular attack score 24: Evaluation of ocular disease activity before and after initiation of infliximab. Jpn J Ophthalmology 58(2): 120-130, 2014.
Nakasato H, Uemoto R, Meguro A, Kawagoe T, Hatano H, Mizuki N: Treatment of symptomatic inferior conjunctivochalasis by ligation. Acta Ophthalmol. 92(5): e411-e412, 2014.
Nishide T, Hayakawa N, Shibuya E, Yagi Y, Mizuki N: Choroidal thickness is affected by many factors which may change the effect of ranibizumab: author's response. Graefes Arch Clin Exp Ophthalmol. 252(5): 849-850, 2014.
Nakasato H, Uemoto R, Isozaki M, Meguro A, Kawagoe T, Mizuki N: Trabeculotomy ab interno with internal limiting membrane forceps for open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 252(6): 977-82, 2014.
Takeuchi M, Kezuka T, Sugita S, Keino H, Namba K, Kaburaki T, Maruyama K, Nakai K, Hirooka K, Hori J, Ohguro N, Sonoda K, Mizuki N, Okada AA, Goto H, Mochizuki M: Evaluation of long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study. Ophthalmology. 121(10): 1877-1884, 2014.
Bakir-Gungor B, Remmers EF, Megura A, Mizuki N, Kastner DL, Gul A, Sezerman OU: Identification of Possible Pathogenic Pathways in Behçet’s Disease Using Genome-wide Association Study Data from Two Different Populations. Eur J Hum Genet. 23(5): 678-687, 2014.
Joshita S, Umemura T, Ota M, Tanaka E. AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis. J Hepatol. 61(6): 1443-1445, 2014.
Umemura T, Katsuyama Y, Yoshizawa K, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E, Ota M. Human leukocyte antigen class II haplotypes affects clinical characteristics and progression of type 1 autoimmune hepatitis in Japan. PLoS One. 9(6): e100565, 2014.
Umemura T, Ota M, Katsuyama Y, Wada S, Mori H, Maruyama A, Shibata S, Nozawa Y, Kimura T, Morita S, Joshita S, Komatsu M, Matsumoto A, Kamijo A, Kobayashi M, Takamatsu M, Yoshizawa K, Kiyosawa K, Tanaka E. KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C. Hum Immunol. 75(8): 822-826. 2014.
Nozawa Y, Umemura T, Katsuyama Y, Shibata S, Kimura T, Morita S, Joshita S, Komatsu M, Matsumoto A, Yoshizawa K, Ota M, Tanaka E. Genetic polymorphism in IFNL4 and response to pegylated interferon-α and ribavirin in Japanese chronic hepatitis C patients. Tissue Antigens. 83(1): 45-48. 2014.
Joshita S, Umemura T, Nakamura M, Katsuyama Y, Shibata S, Kimura T, Morita S, Komatsu M, Matsumoto A, Yoshizawa K, Ishibashi H, Tanaka E, Ota M. STAT4 gene polymorphisms are associated with susceptibility and ANA status in primary biliary cirrhosis. Dis Markers. 2014: 727393.
Ozaki Y, Suzuki S, Shigenari A, Okudaira Y, Kikkawa E, Oka A, Ota M, Mitsunaga S, Kulski JK, Inoko H, Shiina T. HLA-DRB1, -DRB3, -DRB4 and -DRB5 genotyping at a super-high resolution level by long range PCR and high-throughput sequencing. Tissue Antigens. 83(1): 10-16, 2014.
Okuhara S, Umemura T, Joshita S, Shibata S, Kimura T, Morita S, Komatsu M, Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E. Serum levels of interleukin-22 and hepatitis B core-related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B. Hepatol Res. 44(10): E172-80, 2014.
Harayama Y, Kamei S, Sato N, Hayashi T, Shiozaki T, Ota M, Asamura H. Analysis of Y chromosome haplogroups in Japanese population using short amplicons and its application in forensic analysis. Leg Med (Tokyo). 16(1): 20-25, 2014.

このページのトップへ戻る